In this in-depth review, we examine the worldwide epidemiology of SLE and summarize
current knowledge on the influence of race/ethnicity on clinical manifestations, disease …

Introduction: Systemic lupus erythematosus (SLE) is a disease distributed worldwide, which
occurs in both genders, and across racial/ethnic and age groups; however, higher rates are …

Objective Systemic lupus erythematosus (SLE) and lupus nephritis (LN) disproportionately
affect individuals who are members of racial/ethnic minority groups and individuals of lower …

OBJECTIVES: This review examines the burden and patterns of disease in systemic lupus
erythematosus (SLE) and the influence and interactions of gender, ethnicity, age, and …

Objective To examine mortality rates in the largest systemic lupus erythematosus (SLE)
cohort ever assembled. Methods Our sample was a multisite international SLE cohort (23 …

Background Since anecdotal series and small, prospective, controlled trials suggest that
mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are …

Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based …

Objective: In patients with systemic lupus erythematosus (SLE), hydroxychloroquine
prevents disease flares and damage accrual and facilitates the response to mycophenolate …

Clinical and laboratory manifestations and outcome of systemic lupus erythematosus (SLE)
may vary in different populations. A prospective multinational inception cohort should prove …

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with manifold
clinical manifestations and immunological abnormalities, affecting primarily women …